Rare diseases
Investigational molecules
Locations
Back to Italy574 clinical trials in Pisa, Italy across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Long-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
ItalyA study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.
ItalyA study to test if BHV-8000 is effective and safe for adults with early Parkinson's disease
ItalyStudy of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
ItalyPhase III trial evaluating ianalumab with background drug combination in patients with Sjögren's disease
ItalyEfficacy and Safety of DNTH103 in Adults with Generalized Myasthenia Gravis: A Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study
ItalyStudy of GSK5733584 versus paclitaxel or doxorubicin in patients with advanced or recurrent endometrial cancer after platinum‑based chemotherapy and immunotherapy
ItalyA Phase 3 Study of GSK5733584 with drug combination in patients with platinum‑resistant ovarian cancer
ItalyRamantamig (JNJ-79635322) with drug combination versus standard therapy in newly diagnosed multiple myeloma patients not eligible for stem cell transplant
ItalyTargeted peri‑operative prophylaxis using eravacycline (drug combination) versus standard prophylaxis in liver transplant patients colonized with CPE
ItalyFirst‑line Study of RMC‑9805 with Investigator’s Choice Chemotherapy Drug Combination vs Chemotherapy Alone in Patients with Metastatic KRAS G12D‑Mutated Pancreatic Adenocarcinoma
ItalyPhase III Randomized Open‑Label Trial of BNT324 vs Docetaxel Plus Prednisone in Patients with Metastatic Castration‑Resistant Prostate Cancer
ItalyThe busiest research cities in the country
What the registry says about research in the country
Investigating innovative treatments for cardiac conditions and metabolic disorders, with studies focusing on TTR amyloidosis cardiomyopathy and chronic kidney disease management.
Current trials evaluate novel compounds for improving patient outcomes in cardiac conditions and renal disorders.
Comprehensive research into various cancer types, including colorectal cancer, gastric cancer, and lung cancer, testing targeted therapies and innovative treatment combinations.
Advanced clinical trials exploring breakthrough treatments for multiple cancer types.
Studies focusing on chronic inflammatory conditions including Sjögren's Syndrome, psoriatic arthritis, and hidradenitis suppurativa.
Evaluating new therapeutic options for improving quality of life in patients with chronic inflammatory conditions.
Research into respiratory conditions and infectious diseases, including studies on chronic rhinosinusitis and respiratory syncytial virus infections.
Investigating new approaches to treat and prevent respiratory infections and related conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
